The Discounted Cash Flow (DCF) valuation of Cellectis SA (ALCLS.PA) is (23.90) EUR. With the latest stock price at 3.08 EUR, the upside of Cellectis SA based on DCF is -874.8%.
Based on the latest price of 3.08 EUR and our DCF valuation, Cellectis SA (ALCLS.PA) is a sell. selling ALCLS.PA stocks now will result in a potential gain of 874.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 7.8% | 6.4% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (225.68) - (13.30) | (23.90) |
| Upside | -7415.3% - -531.1% | -874.8% |